BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6584406)

  • 1. Mixed passive hemagglutination with soluble platelet antigens.
    Shibata Y; Juji T; Tohyama H; Sakamoto H; Ozawa N; Kano K
    Int Arch Allergy Appl Immunol; 1984; 74(1):93-6. PubMed ID: 6584406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients.
    Heal JM; Blumberg N; Masel D
    Blood; 1987 Jul; 70(1):23-30. PubMed ID: 3474041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-HLA antibody screening with extracted platelet HLA antigens by the mixed passive hemagglutination method.
    Araki N; Shibata Y; Inaba H; Nose Y; Sakata N; Ito K
    Vox Sang; 1995; 69(3):222-30. PubMed ID: 8578735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful management of alloimmunized patients by transfusing HLA compatible and crossmatched platelets.
    Yung CH; Chow MP; Hu HY; Tzeng JL; Mou LL; Deng JM
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Apr; 47(4):228-36. PubMed ID: 1646671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red cells, HLA and platelet antibody formation in patients with multiple transfusions.
    Chow MP; Hu HY; Lyou JY; Lin JS; Yung CH; Lee A; Lee TD
    Acta Haematol; 1994; 92(2):57-60. PubMed ID: 7817704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The detection of platelet antibodies using a modified platelet immunofluorescence test.
    Boisvert A; MacPherson BR
    Am J Clin Pathol; 1983 Dec; 80(6):839-43. PubMed ID: 6356880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a solid phase red blood cell adherence method for pretransfusion platelet compatibility testing.
    Rachel JM; Summers TC; Sinor LT; Plapp FV
    Am J Clin Pathol; 1988 Jul; 90(1):63-8. PubMed ID: 3389344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet transfusion therapy in an alloimmunized patient. The value of crossmatch procedures for donor selection.
    Hecht T; Wolf JL; Mraz L; Scott EP; Patz LD
    JAMA; 1982 Nov; 248(18):2301-3. PubMed ID: 6752444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A flow cytometric platelet immunofluorescence crossmatch for predicting successful HLA matched platelet transfusions.
    Sintnicolaas K; Löwenberg B
    Br J Haematol; 1996 Mar; 92(4):1005-10. PubMed ID: 8616059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unappreciated HLA antibodies in adult immune thrombocytopenic purpura.
    Lin JS; Lyou JY; Chen YJ; Chen PS; Liu HM; Ho CH; Hao TC; Tzeng CH
    J Formos Med Assoc; 2007 Feb; 106(2):105-9. PubMed ID: 17339153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Platelet allo-antibodies identification strategies for preventing and managing platelet refractoriness].
    Basire A; Picard C
    Transfus Clin Biol; 2014 Nov; 21(4-5):193-206. PubMed ID: 25277423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel simple assay system for the detection of human platelet antigen 15 (HPA-15) alloantibodies based on three techniques: an HPA-15 expressing cell line, a monoclonal antibody-specific antigen-capture method and mixed-passive haemagglutination.
    Koh Y; Nishimiya H; Inoue H; Kishigami A; Tsuji Y; Sakamoto R; Hirayama F; Kuroishi A
    Vox Sang; 2020 Feb; 115(2):202-206. PubMed ID: 31777077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet transfusion from donors mismatched for crossreactive HLA antigens.
    Dahlke MB; Weiss KL
    Transfusion; 1984; 24(4):299-302. PubMed ID: 6464151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The kinetics of HLA class I elution and the relevance for the use of HLA-eluted platelet transfusions.
    Novotny VM; Doxiadis IN; van Doorn R; Brand A
    Br J Haematol; 1996 Nov; 95(2):416-22. PubMed ID: 8904902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitization by platelet transfusion.
    Brand A
    Schweiz Med Wochenschr; 1991 Mar; 121(13):467-9. PubMed ID: 2031162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-reactive HLA antibodies associated with low posttransfusion platelet increments:a comparison between the monoclonal antibody-specific immobilization of platelet antigens assay and the lymphocytotoxicity test.
    Kurz M; Knöbl P; Kalhs P; Greinix HT; Höcker P; Panzer S
    Transfusion; 2001 Jun; 41(6):771-4. PubMed ID: 11399818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet absorption on the test tray (PATT): a rapid method for the screening of HLA class II antibodies using the two-colour fluorescence method.
    Cambon-Thomsen A; Sommer E; Demur C; Calot M; Ohayon E
    Tissue Antigens; 1985 Sep; 26(3):193-200. PubMed ID: 3901395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Selection of HLA compatible donors for patients with HLA antibodies].
    Májský A; Korínková P; Kubícková Z
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(6):937-43. PubMed ID: 2419224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA antibody formation within the HLA-A1 crossreactive group in multitransfused platelet recipients.
    MacPherson BR
    Am J Hematol; 1989 Apr; 30(4):228-32. PubMed ID: 2784623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet crossmatch testing for donor selection.
    Slichter SJ
    Prog Clin Biol Res; 1982; 88():153-64. PubMed ID: 7100207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.